Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides

Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverkForskningPeer review

Sammanfattning

WNT signalling is known to be a crucial regulator of embryonic development and tissue homeostasis. Aberrant expression of WNT signalling elements or their mutations has been implicated in carcinogenesis and/or the progression of several different cancer types. Investigations of how WNT signalling affects carcinogenesis and cancer progression have revealed that it has essential roles in the regulation of proliferation, apoptosis, and cancer stemness and in angiogenesis and metastasis. Consequently, WNT-targeted therapy has gained much attention and has resulted in the development of several small molecules, the majority of which act as inhibitors of different WNT signalling events. However, although numerous inhibitory WNT signalling drug candidates have been included in clinical trials, no significant breakthroughs have been made. This could possibly be due to problems with inefficient binding to the target, compensatory signalling mechanisms and toxicity towards normal cells. Therapeutic peptides targeting WNT signalling in cancer cells have been developed as an alternative approach, with the hope that they might overcome the limitations reported for small WNT inhibitory molecules. In this chapter, we describe recent developments made in the design and characterization of WNT signalling-derived peptides aiming at their use as alternative cancer therapeutics and/or combined adjuvant therapy to conventional therapies.
Originalspråkengelska
Titel på värdpublikationHandbook of experimental pharmacology
FörlagSpringer
Sidor279-303
ISBN (elektroniskt)978-3-030-85499-7
ISBN (tryckt)978-3-030-85498-0
DOI
StatusPublished - 2021 aug. 29

Publikationsserier

NamnHandbook of experimental pharmacology
FörlagSpringer
ISSN (elektroniskt)0171-2004

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här